Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-08-24 00:00:00 ET · period of report 2022-08-22 · accession 0001209191-22-047354 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-24 | 2022-08-22 | PCVX | Sauer Paul | SVP Process Dev, Manufacturing | S - Sale | $25.93 | -3,000 | 14.7K | -17% | -$77.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-22 | S | D | 3,000 | $25.93 | 14,687 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $25.685 to $26.09. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |